Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients.


Insulin resistance contributes to the metabolic defects in non-insulin dependent diabetes mellitus (NIDDM). Anorectic agents have been shown to improve insulin action in NIDDM, irrespective of weight reduction. In a double-blind placebo-controlled cross-over study, we examined hepatic and peripheral insulin action by the sequential hyperinsulinaemic-euglycaemic clamp technique with infusion of 3-[3H]-glucose in eight obese NIDDM patients and in eight obese non-diabetics, matched for age, sex and body mass index. Body weight was kept constant. After 14 days of fluoxetine, 60 mg daily, in NIDDM half-maximal peripheral glucose uptake was achieved at a lower insulin level than after placebo (ED50pgu: 180.5 +/- 25.8 vs. 225.3 +/- 39.9 mU/l, P < 0.05), but not in non-diabetics (140 +/- 15.3 vs. 135.3 +/- 22.2 mU/l, n.s.). Maximal peripheral glucose uptake (Vmaxpgu) did not change significantly. Multivariate analysis disclosed no differences in the effect of fluoxetine between NIDDM and non-diabetics. When non-diabetics and NIDDM were considered together, only the most insulin-resistant individuals demonstrated a decrease in ED50pgu (P < 0.001). Likewise, only the individuals with the most outspoken hepatic insulin resistance demonstrated a decrease in insulin level, at which hepatic glucose production (HGP) is completely suppressed (HGP0) (P < 0.01). In conclusion, fluoxetine improves peripheral and hepatic insulin action in obese insulin-resistant subjects irrespective of its weight lowering effect.


Citations per Year

337 Citations

Semantic Scholar estimates that this publication has 337 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Loon1992FluoxetineII, title={Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients.}, author={Bert Jan Potter van Loon and Jasper K Radder and Marijke Fr{\"{o}lich and H. Michiel J. Krans and Aeilko H. Zwinderman and A Edo Meinders}, journal={International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity}, year={1992}, volume={16 Suppl 4}, pages={S55-61} }